Literature DB >> 10377242

Kinetic and inhibition studies on substrate channelling in the bifunctional enzyme catalysing C-terminal amidation.

A B Moore1, S W May.   

Abstract

A series of experiments has been conducted to investigate the possibility that substrate channelling might occur in the bifunctional forms of enzymes carrying out C-terminal amidation, a post-translational modification essential to the biological activity of many neuropeptides. C-terminal amidation entails sequential action by peptidylglycine mono-oxygenase (PAM, EC 1.14.17.3) and peptidylamidoglycolate lyase (PGL, EC 4.3.2.5), with the mono-oxygenase catalysing conversion of a glycine-extended pro-peptide into the corresponding alpha-hydroxyglycine derivative, which is then converted by the lyase into amidated peptide plus glyoxylate. Since the mono-oxygenase and lyase reactions exhibit tandem reaction stereospecificities, channelling of the alpha-hydroxy intermediate might occur, as is the case for some other multifunctional enzymes. Selective inhibition of the mono-oxygenase domain by competitive ester inhibitors, as well as mechanism-based mono-oxygenase inactivation by the novel olefinic inhibitor 5-acetamido-4-oxo-6-phenylhex-2-enoate (N-acetylphenylalanyl acrylate), has little to no effect on the kinetic parameters of the lyase domain of the AE from Xenopus laevis. Similarly, inhibition of the lyase domain by the potent dioxo inhibitor 2,4-dioxo-5-acetamido-6-phenylhexanoate has little effect on the activity of the monooxygenase domain in the bifunctional enzyme. A series of experiments on intermediate accumulation and conversion were also carried out, along with kinetic investigations of the reactivities of the monofunctional and bifunctional forms of PAM and PGL towards substrates and inhibitors. Taken together, the results demonstrate the kinetic independence of the mono-oxygenase and lyase domains, and provide no evidence for substrate channelling between these domains in the bifunctional amidating enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377242      PMCID: PMC1220327     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  Biosynthesis of the C-terminal amide in peptide hormones.

Authors:  A F Bradbury; D G Smyth
Journal:  Biosci Rep       Date:  1987-12       Impact factor: 3.840

2.  The reaction product of peptidylglycine alpha-amidating enzyme is a hydroxyl derivative at alpha-carbon of the carboxyl-terminal glycine.

Authors:  M Tajima; T Iida; S Yoshida; K Komatsu; R Namba; M Yanagi; M Noguchi; H Okamoto
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

3.  4-Phenyl-3-butenoic acid, an in vivo inhibitor of peptidylglycine hydroxylase (peptide amidating enzyme).

Authors:  A F Bradbury; J Mistry; B A Roos; D G Smyth
Journal:  Eur J Biochem       Date:  1990-04-30

4.  Cloning and sequence of cDNA encoding a peptide C-terminal alpha-amidating enzyme from Xenopus laevis.

Authors:  K Mizuno; K Ohsuye; Y Wada; K Fuchimura; S Tanaka; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1987-10-29       Impact factor: 3.575

Review 5.  Peptide alpha-amidation.

Authors:  B A Eipper; R E Mains
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

6.  Purification of a peptidylglycine alpha-amidating enzyme from transplantable rat medullary thyroid carcinomas.

Authors:  N M Mehta; J P Gilligan; B N Jones; A H Bertelsen; B A Roos; R S Birnbaum
Journal:  Arch Biochem Biophys       Date:  1988-02-15       Impact factor: 4.013

7.  Allosteric interactions coordinate catalytic activity between successive metabolic enzymes in the tryptophan synthase bienzyme complex.

Authors:  P S Brzović; K Ngo; M F Dunn
Journal:  Biochemistry       Date:  1992-04-21       Impact factor: 3.162

8.  Purification and characterization of peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary.

Authors:  A S Murthy; R E Mains; B A Eipper
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

9.  Methylenetetrahydrofolate dehydrogenase - methenyltetrahydrofolate cyclohydrolase - formyltetrahydrofolate synthetase from porcine liver: evidence to support a common dehydrogenase-cyclohydrolase site.

Authors:  D Drummond; S Smith; R E MacKenzie
Journal:  Can J Biochem Cell Biol       Date:  1983-11

10.  Peptide C-terminal alpha-amidating enzyme purified to homogeneity from Xenopus laevis skin.

Authors:  K Mizuno; J Sakata; M Kojima; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1986-06-30       Impact factor: 3.575

View more
  3 in total

1.  Amidation inhibitors 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester are novel HDAC inhibitors with anti-tumorigenic properties.

Authors:  Amna Ali; Timothy J Burns; Jacob D Lucrezi; Sheldon W May; George R Green; Diane F Matesic
Journal:  Invest New Drugs       Date:  2015-06-13       Impact factor: 3.850

2.  Kinetic and stereochemical studies on novel inactivators of C-terminal amidation.

Authors:  J Feng; J Shi; S R Sirimanne; C E Mounier-Lee; S W May
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

Review 3.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.